Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

Complex PCI Not Without Risk in Elderly Patients With SIHD: Yale Study

News Daily News

Complex PCI Not Without Risk in Elderly Patients With SIHD: Yale Study

October 10, 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

Deferred Testing in Low-Risk Patients Safe, May Curb Symptoms: PRECISE

News Daily News

Deferred Testing in Low-Risk Patients Safe, May Curb Symptoms: PRECISE

Yael L. Maxwell

August 23, 2023

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

News Daily News

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Michael O'Riordan

July 18, 2023

Revamped AUC in Chronic Coronary Disease Reflect Changing Practice

News Daily News

Revamped AUC in Chronic Coronary Disease Reflect Changing Practice

June 02, 2023

Many ACS Patients With Occlusions Are Falling Through the Cracks

News Conference News EuroPCR 2023

Many ACS Patients With Occlusions Are Falling Through the Cracks

May 19, 2023

On-site Machine Learning-Based FFRCT Feasible, Informative: TARGET

News Conference News ACC 2023

On-site Machine Learning-Based FFRCT Feasible, Informative: TARGET

March 04, 2023

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

‘Total Ischemic Time’ Key to Cutting NSTEMI Deaths With Invasive Strategy

News Daily News

‘Total Ischemic Time’ Key to Cutting NSTEMI Deaths With Invasive Strategy

Yael L. Maxwell

January 11, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.